Comparison of Two Pulmonary Valve Replacement Methods to Treat Tetralogy of Fallot
Randomized Trial of Pulmonary Valve Replacement in Tetralogy of Fallot
3 other identifiers
interventional
68
1 country
1
Brief Summary
Repair of tetralogy of Fallot (TOF), the most common form of cyanotic congenital heart disease, usually involves surgery on the outflow of the right ventricle (RV) and the pulmonary valve in order to relieve obstruction to blood flow from the RV to the lungs. This procedure often leads to regurgitation (leakage) of the pulmonary valve, which puts the burden of handling a larger than normal amount of blood flow on the RV. Over the years, that extra burden leads to enlargement of the RV and to a decrease in its function. Treatment often includes surgical insertion or replacement of a new pulmonary valve. Replacement of the damaged pulmonary valve aims to minimize the leakage and help the RV function better. This study is designed to compare two methods of how the operation (called pulmonary valve replacement \[PVR\]) is performed. In the first method, a new valve is inserted and only the area of the old valve is operated on; this is the standard PVR. The second method involves inserting the new valve in the same way as the standard method but, in addition, areas of the right ventricular wall that are scarred and not functioning well are removed (PVR plus right ventricular remodeling). This study will evaluate which method is more effective based on the size and function of the RV measured by cardiac magnetic resonance imaging (CMR) six months following surgery, as compared to its size and function before the operation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2004
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2004
CompletedFirst Submitted
Initial submission to the registry
June 1, 2005
CompletedFirst Posted
Study publicly available on registry
June 2, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedDecember 4, 2012
December 1, 2012
7.3 years
June 1, 2005
December 3, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in ventricular mechanics compared with the preoperative ventricular mechanics
Measured at 6 months
Secondary Outcomes (1)
Incidence of one or more postoperative adverse events
Measured at 6 months
Study Arms (2)
1
ACTIVE COMPARATORStandard PVR
2
EXPERIMENTALPVR plus RV remodeling
Interventions
PVR and surgical RV remodeling, which includes bioprosthetic pulmonary valve insertion and resection of akinetic scarred areas on the anterior RV wall to reduce RV volume
PVR alone, which includes bioprosthetic pulmonary valve insertion and, when present, resection of right ventricular outflow tract (RVOT) aneurysm
Eligibility Criteria
You may qualify if:
- Undergoing PVR to repair TOF at Children's Hospital Boston
- Pulmonary regurgitation fraction greater than or equal to 25% (measured by CMR) and two or more of the following criteria:
- RV end-diastolic volume index greater than or equal to 150 ml/m2 (Z score greater than 5)
- RV end-systolic volume index greater than or equal to 70 ml/m2
- LV end-diastolic volume index less than or equal to 65 ml/m2
- RV ejection fraction less than 45%
- RVOT aneurysm
- Clinical criteria: exercise intolerance, symptoms and signs of heart failure, and use of cardiac medications
You may not qualify if:
- Presence of either severe RV outflow tract obstruction (defined as peak-to-peak systolic gradient of greater than or equal to 60 mm Hg by cardiac catheterization) or severe RV hypertension at systemic or higher level
- Additional sources of RV volume overload other than PR and tricuspid valve regurgitation
- Contraindications to CMR
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Cardiology, Children's Hospital Boston
Boston, Massachusetts, 02115, United States
Related Publications (1)
Geva T, Gauvreau K, Powell AJ, Cecchin F, Rhodes J, Geva J, del Nido P. Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation. 2010 Sep 14;122(11 Suppl):S201-8. doi: 10.1161/CIRCULATIONAHA.110.951178.
PMID: 20837914DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tal Geva, MD
Boston Children's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Study coordinator
Study Record Dates
First Submitted
June 1, 2005
First Posted
June 2, 2005
Study Start
April 1, 2004
Primary Completion
August 1, 2011
Study Completion
August 1, 2011
Last Updated
December 4, 2012
Record last verified: 2012-12